SMTL ID : 4s0v.1

Crystal structure of the human OX2 orexin receptor bound to the insomnia drug Suvorexant

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 2.50 Å

Oligo State

monomer

Ligands

1 x SUV: [(7R)-4-(5-chloro-1,3-benzoxazol-2-yl)-7-methyl-1,4-diazepan-1-yl][5-methyl-2-(2H-1,2,3-triazol-2-yl)phenyl]methanone(Non-covalent)

SUV.1: 19 residues within 4Å: Chain A: A.116, T.117, V.120, W.126, I.136, P.137, Q.140, T.141, V.144, Q.193, E.218, H.230, F.233, Y.480, I.483, N.487, H.513, V.516, Y.517 6 PLIP interactions: 6 interactions with chain A Hydrophobic interactions: A:T.117, A:I.136, A:Q.140, A:V.516 Hydrogen bonds: A:Q.140, A:N.487

1 x OLA: OLEIC ACID(Non-functional Binders)

OLA.2: 0 residues within 4Å: (No contacts) No protein-ligand interaction detected (PLIP)

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Yin, J. et al., Crystal structure of the human OX2 orexin receptor bound to the insomnia drug suvorexant. Nature (2015)

Release Date

2015-01-14

Peptides

Human Orexin receptor type 2 fusion protein to P. abysii Glycogen Synthase: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Membrane

We predict this structure to be a membrane protein.
Show / Hide

Human Orexin receptor type 2 fusion protein to P. abysii Glycogen Synthase